References of "Melin, Pierrette"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailTowards a Belgian Consensus for prevention of perinatal group B streptococcal disease
MELIN, Pierrette ULg; Verschraegen, G.; Mahieu, Ludo et al

Conference (2002, October)

Background & objectives: In Belgium, as in many other countries, group B Streptococcus (GBS) is still the leading cause of sepsis and meningitis in neonates. In 2001, though no Belgian guidelines for ... [more ▼]

Background & objectives: In Belgium, as in many other countries, group B Streptococcus (GBS) is still the leading cause of sepsis and meningitis in neonates. In 2001, though no Belgian guidelines for their prevention were available, in some hospitals, obstetrical programmes included a GBS prevention policy. With an aim to reach a Belgian consensus for the prevention of perinatal group B streptococcal disease, a national consensum meeting was organized in 2001. We report here our experience and findings of this meeting. Methods: In November 2001, obstetricians, neonatologists, microbiologists and infectious diseases specialists were invited to participate in a GBS symposium. International and Belgian speakers presented epidemiological aspects, argued comparative cost-effectiveness of different approaches for prevention and debated technical and practical problems. Management of neonates with risk factors for GBS disease and progress in GBS vaccines were also included in the programme. Further results about Belgian obstetricians’ practice and compliance to a policy for prevention of neonatal GBS diseases, as answered in two mail surveys, were commented and discussed. In an interactive session at the end, each participant was asked to vote on the key points related to the different steps of the ideal prevention strategy to recommend. Results: For the main questions, 94 per cent of participants choose a screening-based approach and 94 per cent shifted from the current use of ampicillin to penicillin as first choice for antimicrobial prophylaxis. Further, 79 per cent voted for an approach with integrated neonatal prophylaxis for selected neonates at high risk for GBS disease and 47 per cent voted for a strategy based on an intrapartum rapid screening-based approach. Interpretation & conclusion: The state of the question by different speakers, the data from Belgian epidemiology, and the debate about cost-effectiveness of different approaches led to a massive vote in favour of the universal screening-based approach. Based on these results, a working group has been appointed by the Ministry of Health to draft and edit Belgian recommendations for the prevention of perinatal GBS disease. [less ▲]

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailSerotype Distribution of clinical isolates of group B streptococci Isolated in Belgium : isolates from neonatal infection compared to isolates from infection in adult or colonization in pregnant women
MELIN, Pierrette ULg; Keke, D.; Campo, B. et al

in American Society of Microbiology (Ed.) Program and Abstracts of the 43rd Intersciences Conference on Antimicrobial Agents and Chemotherapy (2002, September)

Background: Group B Streptococci cause invasive disease in neonates, pregnant women and non-pregnant adults. In the last decades capsular serotypes (type) Ia, Ib, II and III caused the majority of ... [more ▼]

Background: Group B Streptococci cause invasive disease in neonates, pregnant women and non-pregnant adults. In the last decades capsular serotypes (type) Ia, Ib, II and III caused the majority of clinical diseases. More recently, in North America, type V emerged as the more common type in non-pregnant adults with invasive disease. Methods: From January 1999 through December 2001, we received and typed a total of 334 clinically significant strains of GBS isolated in the laboratories belonging to the Belgian network for epidemiological surveillance. 113 were recovered from neonates blood or cerebrospinal fluid (92 early onset EOD, 21 late onset LOD), 14 were isolated from pregnant women with severe infections and 204 were recovered from adults with invasive disease. From the same laboratories, during the first trimester of 2002, 302 isolates from pregnant women were also typed (max. 5 isolates /lab.) Results: In neonatal EOD type III was the more common (41,3%) followed by II (19.6%), Ia (16.3%), Ib (13%), V (8.7%) and IV (1.1%), whereas type III caused the majority (85.7%) of LOD cases. In adults, all types were well represented except type IV: 20.3% Ia, 12.7% Ib, 13.1% II, 23.1% III, 2.7% IV, 19% V and 9% remained non typeable (NT). In colonized pregnant women, all types were also well represented except type IV: 25.5% Ia, 13.3% Ib, 14.9% II, 17.7% III, 5% IV, 15.5% V and 8.1% remained NT. Type III was more frequently the cause of EOD than a colonizing strain during pregnancy and in contrast NT isolates did not cause EOD (P<0.001) Conclusions: 1) Type III was still the major type in neonatal infections in Belgium. 2) Type distribution of GBS differed by age-group of patients 3) Type V belonged to the 3 more represented types in adults 4) Compared to colonizing GBS in pregnant women, distribution of types causing EOD was different. [less ▲]

Detailed reference viewed: 9 (0 ULg)
Full Text
See detailBiological warfare and terrorism, the dark side of microbiology
Melin, Pierrette ULg

Scientific conference (2002, September)

Detailed reference viewed: 11 (0 ULg)
Full Text
See detailThe Flesh-Eating Bacteria
Melin, Pierrette ULg

Scientific conference (2002, September)

Detailed reference viewed: 9 (0 ULg)
Full Text
Peer Reviewed
See detailIn Vitro Susceptibility Testing of Aspergillus fumigatus against Posaconazole: Comparison of NCCLS M38-P and E-Test Methods
Hayette, Marie-Pierre ULg; Amadore, Agatha; Seidel, Laurence ULg et al

Poster (2002, September)

Posaconazole is a second-generation triazole and structural analogue of itraconazole. This drug has fungicidal activity against yeasts and filamentous fungi. The aim of our study was to evaluate E-test ... [more ▼]

Posaconazole is a second-generation triazole and structural analogue of itraconazole. This drug has fungicidal activity against yeasts and filamentous fungi. The aim of our study was to evaluate E-test method for in vitro susceptibility testing of Aspergillus fumigatus isolates against posaconazole. METHODS: A total of 121 isolates of A. fumigatus were selected as follows: 106 clinical strains from colonized patients, 18 from patients with invasive aspergillosis and 7 environmental isolates. Their in vitro susceptibility was evaluated by E-test (Abbiodisk, Sweden) and compared with NCCLS microdilution reference method (M38-P). Both tests were performed with RPMI 1640 medium at 35 degrees C. MIC values were read after 24h (MIC-24h) and 48h (MIC-48h) incubation time by E-test method. Two MIC endpoints were determined by NCCLS method: 1.no visible reduction of growth (MIC-0); 2. 50% reduction (or more) of growth (MIC-2). Three A. fumigatus reference strains (IHEM 5734, 6149 and 13935) were included as control. RESULTS: Geometric mean MICs (microg/ml) were respectively 0.02 for E-test at 24h and 0.029 at 48h. MIC-0 and MIC-2 values were respectively 0.19 and 0.018 microg/ml. One correlation between both methods was observed for MICs-24h and MICs-2s (p<.05). However, there was no significant difference according to origin of isolates (p<.05). CONCLUSIONS: 1. This study assessed the potent role of posaconazole against A. fumigatus isolates with very low MICs. 2. MIC values were not predictive of pathogenicity. 3. E-test method by reading after 24h-incubation time could easily replace the time-consuming NCCLS M38-P reference method. [less ▲]

Detailed reference viewed: 33 (0 ULg)
See detailInfections et grossesse
MELIN, Pierrette ULg

Conference (2002, March 16)

Detailed reference viewed: 8 (0 ULg)
See detailGroup B Streptococcal Infections in Belgium
Melin, Pierrette ULg

Conference (2002, March 13)

Detailed reference viewed: 7 (0 ULg)
See detailGroup B Streptococcal infections in Belgium
MELIN, Pierrette ULg

Conference (2001, December)

Detailed reference viewed: 9 (0 ULg)
Peer Reviewed
See detailComparative In Vitro Activity of Amphotericine B, Itraconazole, Voriconazole and Posaconazole against Aspergillus fumigatus
Hayette, Marie-Pierre ULg; Amadore, Agatha; Seidel, Laurence ULg et al

Poster (2001, December)

Background. New azoles have been successfully used as treatment of invasive aspergillosis. The purpose of this study was to compare the in vitro activity of posaconazole (Posa) with that of amphotericin B ... [more ▼]

Background. New azoles have been successfully used as treatment of invasive aspergillosis. The purpose of this study was to compare the in vitro activity of posaconazole (Posa) with that of amphotericin B (AmB), itraconazole (Itra) and voriconazole (Vor) against A. fumigatus isolates according to NCCLS method (M38-P), and to compare visual and spectrophotometric readings for MIC determination. Methods. A total of 106 A. fumigatus isolates were selected as follows: 88 clinical isolates from colonized patients, 18 from patients with invasive aspergillosis and 7 environmental isolates. Their in vitro susceptibility was evaluated by the NCCLS microdilution method (M38-P) in RPMI 1640 medium. Determination of results was made by visual and spectrophotometric readings (630 nm) after 48 hours incubation at 35 degreesC. Three A. fumigatus reference strains (IHEM 5734, 6149 and 13935) were included as control. Results. 1. Geometric mean MICs/MIC90 (microg/ml) obtained by visual reading were respectively 0.66/1 (AmB), 0.37/0.5 (Itra), 0.27/0.5 (Vor) and 0.02/0.03 (Posa). 2. MIC values were comparable by spectrophotometric and by visual readings for all antifungal agents tested (p>.05) and did not depend on the isolates origin (p>.05). 3. Posaconazole had the lowest MICs (p< 0.001). 4. The itraconazole-resistant reference strain did not give cross resistance with voriconazole and posaconazole. CONCLUSIONS: Among azoles, posaconazole had a better in vitro activity against A. fumigatus than did voriconazole or itraconazole. Spectrophotometric reading could replace the less standardized visual reading for NCCLS microdilution method and MIC values obtained were comparable among all A. fumigatus isolates. [less ▲]

Detailed reference viewed: 63 (0 ULg)
See detailGroup B Streptococcal Infections in Belgium
MELIN, Pierrette ULg

Conference (2001, November 30)

Detailed reference viewed: 9 (0 ULg)
See detailPrevention of perinatal GBS Diseases: Recommendations in European Countries, Proposal for Belgium
MELIN, Pierrette ULg

Scientific conference (2001, November 17)

Detailed reference viewed: 9 (0 ULg)
See detailGroup B streptococcal policies in the French Community of Belgium
MELIN, Pierrette ULg

Scientific conference (2001, November 17)

Detailed reference viewed: 7 (0 ULg)
See detailGroup B streptococcal Screening
MELIN, Pierrette ULg

Scientific conference (2001, November 17)

Detailed reference viewed: 5 (0 ULg)
See detailGroup B Streptococcal infections
MELIN, Pierrette ULg

Scientific conference (2001, November 17)

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailPrevalence of ermB, ermTR and mefA/B gene classes among erythromycine resistant group B streptococcus isolates collected in Belgium
MELIN, Pierrette ULg; Rodriguez Cuns, Grisel; Tsobo, Chantal et al

Poster (2001, October)

Background: Emergence of erythromycin (Er) and clindamycin (C) resistance (R) observed in GBS, is currently becoming recognized. Methods: Clinical isolates were obtained from a Belgian surveillance for ... [more ▼]

Background: Emergence of erythromycin (Er) and clindamycin (C) resistance (R) observed in GBS, is currently becoming recognized. Methods: Clinical isolates were obtained from a Belgian surveillance for invasive GBS disease in newborns and adults in 1996-1998 (N1=235) and from consecutive specimens submitted, during 1999-2000, to the University hospital of Liege (N2=165). MICs of Er were determined buy using Etest® strip (interpretive criteria of NCCLS). Furthermore, for the ErR isolates, the inducible (iMLS), constitutive (cMLS) and M phenotypes were assessed by disk diffusion and by a double-disk test; the distribution of genes encoding RNA methylases and efflux pumps was investigated by PCR. Results: Of the N1 and N2 isolates, 16 (6.8%) and 19 (11.5%) were respectively R to Er. Among these 35 ErR isolates, 21 (60%) exhibited the cMLS phenotype. They demonstrated a high level R to Er with MICs ranging from 16 to >256 mg/L. The ermB gene was harbored by 19/21 isolates, the ermTR gene by 1 isolate and both ermB and ermTR were present in another isolate. The iMLS phenotype was observed in 10 (29%) ErR isolates; the ermTR gene was present in all isolates except one harboring an ermTR gene. These strains demonstrated low level of R to Er, with MICs of 1-12 mg/L. All 4 isolates (11%) expressing an M phenotype, displayed low level R to Er alone (MICs, 2 mg/L) and were positive for the mefA/B gene. Conclusion: In Belgium, by year 2000, prevalence of R to macrolide in GBS exceeded 10%. R was mainly caused by target-site modification (ermB, ermTR) mechanisms; efflux (mefA/B) R mechanism was also prevalent among the isolates tested. These results indicate the possibility of inappropriate prophylaxis or therapy using C or E as the recommended alternatives in penicillin-allergic patients. [less ▲]

Detailed reference viewed: 47 (0 ULg)
See detailAutomation in Identification and Susceptibility Testing
Melin, Pierrette ULg; De Mol, Patrick ULg

Conference (2001, June 14)

Detailed reference viewed: 10 (1 ULg)
See detailAutomatisation in blood cultures
Melin, Pierrette ULg; De Mol, Patrick ULg

Conference (2001, June 14)

Detailed reference viewed: 9 (2 ULg)